Bill > H2503

This bill aims to reduce risks associated with allergic reactions by allowing businesses and other entities to obtain and use epinephrine auto-injectors (commonly known as EpiPens) in emergency situations. The bill requires the Department of Public Health to create regulations that permit businesses to keep epinephrine auto-injectors on-site for use in potential anaphylaxis emergencies, even for individuals who do not have a prior prescription. Businesses and their employees who administer the epinephrine will be protected from liability for ordinary negligence when acting in good faith to help someone experiencing a severe allergic reaction. The bill mandates that businesses develop training programs for employees on recognizing allergic reaction symptoms, proper storage and administration of epinephrine, and emergency follow-up procedures. The training can be conducted online and must be overseen by a licensed physician, nurse practitioner, or a nationally recognized emergency health training organization. Additionally, the bill requires businesses to report incidents involving severe allergic reactions, and the Department of Public Health will compile an annual report analyzing these incidents. The department may also establish a certification program to recognize businesses that maintain an "allergy-friendly environment" and comply with the new regulations.

Health and Social Services

https://malegislature.gov/Bills/194/H2503